Carmat SA (CXT.F)
| Previous Close | 3.0800 |
| Open | 3.1500 |
| Bid | 3.1850 x 11300 |
| Ask | 3.2400 x 11100 |
| Day's Range | 3.1100 - 3.2000 |
| 52 Week Range | 2.8850 - 9.4200 |
| Volume | |
| Avg. Volume | 171 |
| Market Cap | 110.821M |
| Beta (5Y Monthly) | 1.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at Its Annual General Meeting
PARIS, May 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), informs its shareholders that the Combined General Meeting (AGM) held on May 30, 2024, was able to validly deliberate, the required quorum having been reached.
- Business Wire
CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook
PARIS, May 06, 2024--CARMAT continues to build on its momentum in the EFICAS study and reiterates confidence in its 2024 outlook
- Business Wire
CARMAT : Availability of the 2023 Universal Registration Document
PARIS, April 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announced the publication of the Company’s Universal registration document ("URD") for the year ended December 31, 2023.
